Circular RNA hsa_circ_0000263 participates in cervical cancer development by regulating target gene of miR‐150‐5p

H Cai, P Zhang, M Xu, L Yan, N Liu… - Journal of Cellular …, 2019 - Wiley Online Library
Circular RNA (circRNA) is a new class of noncoding RNA, and plays an important role in
many pathological processes. Cervical cancer is the most common gynecologic malignant …

[HTML][HTML] Multiple functions and regulatory network of miR-150 in B lymphocyte-related diseases

YZ Hu, Q Li, PF Wang, XP Li, ZL Hu - Frontiers in Oncology, 2023 - frontiersin.org
MicroRNAs (miRNAs) play vital roles in the post-transcriptional regulation of gene
expression. Previous studies have shown that miR-150 is a crucial regulator of B cell …

[HTML][HTML] Opposite prognostic significance of cellular and serum circulating microRNA-150 in patients with chronic lymphocytic leukemia

B Stamatopoulos, M Van Damme, E Crompot… - Molecular …, 2015 - Springer
MicroRNAs (or miRs) play a crucial role in chronic lymphocytic leukemia (CLL)
physiopathology and prognosis. In addition, circulating microRNAs in body fluids have been …

[HTML][HTML] MicroRNA-150 predicts a favorable prognosis in patients with epithelial ovarian cancer, and inhibits cell invasion and metastasis by suppressing …

M Jin, Z Yang, W Ye, H Xu, X Hua - PloS one, 2014 - journals.plos.org
MicroRNA (miR)-150 has been reported to be dramatically downregulated in human
epithelial ovarian cancer (EOC) tissues and patients' serum compared to normal controls …

[HTML][HTML] MiRNA dysregulation in childhood hematological cancer

J Carvalho de Oliveira, G Molinari Roberto… - International journal of …, 2018 - mdpi.com
For decades, cancer biology focused largely on the protein-encoding genes that have clear
roles in tumor development or progression: cell-cycle control, apoptotic evasion, genome …

[PDF][PDF] miR-150 is a factor of survival in prostate cancer patients

L Dezhong, Z Xiaoyi, L Xianlian, Z Hongyan, Z Guohua… - J buon, 2015 - jbuon.com
Purpose: Prostate cancer (PC) is the most common malignant disease in males and the
second leading cause of cancer related deaths in men in developed countries. The purpose …

[HTML][HTML] MicroRNA profiles in B-cell non-Hodgkin lymphoma

Z Getaneh, F Asrie, M Melku - Ejifcc, 2019 - ncbi.nlm.nih.gov
B-cell non-Hodgkin's lymphomas are tumors of B-cells that arise following clonal expansion
and consequent invasion of immune organs by B-cells blocked at a certain step of the …

[HTML][HTML] Dasatinib reverses drug resistance by downregulating MDR1 and Survivin in Burkitt lymphoma cells

M Tabata, M Tsubaki, T Takeda, K Tateishi… - … medicine and therapies, 2020 - Springer
Abstract Background Current chemotherapies for Burkitt lymphoma (BL) have dramatically
improved its clinical outcome. However, chemoresistance can lead to chemotherapy failure …

[HTML][HTML] MiR-150-5p May Contribute to Pathogenesis of Human Leiomyoma via Regulation of the Akt/p27Kip1 Pathway In Vitro

JH Lee, YS Choi, JH Park, H Kim, I Lee… - International Journal of …, 2019 - mdpi.com
Uterine leiomyoma is found in~ 50–80% of women of a reproductive age and is the most
common reason for hysterectomy. Recently, posttranscriptional gene silencing by …

[HTML][HTML] Intricate crosstalk between MYB and noncoding RNAs in cancer

D Hu, W Shao, L Liu, Y Wang, S Yuan, Z Liu… - Cancer Cell …, 2021 - Springer
MYB is often overexpressed in malignant tumors and plays a carcinogenic role in the
initiation and development of cancer. Deletion of the MYB regulatory C-terminal domain may …